Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Analysis

Editor-in-Chief

ISSN (Print): 1573-4129
ISSN (Online): 1875-676X

Back
Research Article

Method Development of Clarithromycin by Chromophore Addition through Chemical Derivatization

Author(s): Murad Abualhasan*, Amal Qato, Salam Qrareya and Tasneem Khassib

Volume 17, Issue 6, 2021

Published on: 15 April, 2020

Page: [822 - 828] Pages: 7

DOI: 10.2174/1573412916999200415180046

Price: $65

Abstract

Introduction: Clarithromycin is a macrolide antibiotic that is active against a variety of microorganisms. It is widely used in the local and international market in different pharmaceutical dosage forms. However, its chemical structure lacks a chromophore and hence it has a low absorption and this makes it more difficult to be detected at low concentrations. In this research project, we proposed an easy and feasible chemical derivatization of clarithromycin to introduce a chromophore in order to increase its absorptivity at low concentration using a simple reverse phase HPLC analytical method.

Methodology: Chemical derivatization of clarithromycin involved an introduction of benzoyl groups as a chromophore through esterification reaction. A reverse phase analytical HPLC method was developed to quantify clarithromycin at a very low concentration compared to the standard official pharmacopeia.

Results: Clarithromycin was successfully derivatized and a hyperchromic and bathochromic shift to UV absorption lambda max (λmax) was achieved (λmax = 245nm.) A successful chromatographic separation was obtained using reverse phase HPLC chromatography. The developed method was capable of detecting and quantifying clarithromycin at very low concentration. The Limit of Quantification (LOD) and Limit of Quantification (LOQ) was found to be 2*10-8 mg/ml and 2*10-6 mg/ml respectively.

Conclusion: Clarithromycin was successfully derivatized to a chromophore containing molecule. The developed reverse phase HPLC method is capable to detect and quantify clarithromycin at a very low concentration. The method can successfully quantify clarithromycine when present in low concentration such as in biological and enviromental samples.

Keywords: Clarithromycin, HPLC, derivatization, chromophore, coupling, spectroscopy.

« Previous
Graphical Abstract

[1]
National Center for Biotechnology Information. PubChem Compound Database; CID=84029,. https://pubchem.ncbi.nlm.nih.gov/compound/84029 (accessed May 4, 2018)
[2]
https://www.drugs.com/clarithromycin.html ( accessed accessed June 10, 2018)
[3]
Clarithromycin Side Effects in Detail - Drugs.com Drugs.com. Archived from the original on , 2017-08-19. Retrieved 2017-08-18.
[4]
Taubert, K.A.; Dajani, A.S. Preventing bacterial endocarditis: american heart association guidelines. Am. Fam. Physician, 1998, 57(3), 457-468.
[PMID: 9475895]
[5]
Foroutan, S.M.; Zarghi, A.; Shafaati, A.; Madadian, B.; Abolfathi, F. Rapid high performance liquid chromatographic method for determination of clarithromycin in human plasma using amperometric detection: application in pharmacokinetic and bioequivalence studies. Iran. J. Pharm. Res., 2013, 12(Suppl.), 65-69.
[PMID: 24250673]
[6]
Shin, J.; Pauly, D.F.; Johnson, J.A.; Frye, R.F. Simplified method for determination of clarithromycin in human plasma using protein precipitation in a 96-well format and liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2008, 871(1), 130-134.
[http://dx.doi.org/10.1016/j.jchromb.2008.06.050] [PMID: 18639501]
[7]
Lotfipour, F.; Valizadeh, H.; Hallaj-Nezhadi, S.; Milani, M.; Zakeri-Milani, P. Comparison of microbiological and high-performance liquid chromatographic methods for determination of clarithromycin levels in plasma. Iran. J. Pharm. Res., 2010, 9(1), 27-35.
[PMID: 24363703]
[8]
Wibawa, J.I.; Shaw, P.N.; Barrett, D.A. Quantification of clarithromycin, its 14-hydroxy and decladinose metabolites in rat plasma, gastric juice and gastric tissue using high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2003, 783(2), 359-366.
[http://dx.doi.org/10.1016/S1570-0232(02)00765-1] [PMID: 12482478]
[9]
Kees, F.; Spangler, S.; Wellenhofer, M. Determination of macrolides in biological matrices by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. A, 1998, 812(1-2), 287-293.
[http://dx.doi.org/10.1016/S0021-9673(97)01279-X] [PMID: 9691325]
[10]
Jain, A.; Jain, A.; Jain, A. Sensitive polarographic electrochemical determination of clarithromycin in blood serum. J. Young Pharm., 2013, 5(2), 70-72.
[http://dx.doi.org/10.1016/j.jyp.2013.06.005] [PMID: 24023459]
[11]
van Rooyen, G.F.; Smit, M.J.; De Jager, A.D.; Hundt, H.K.; Swart, K.J.; Hundt, A.F. Sensitive liquid chromatography-tandem mass spectrometry method for the determination of clarithromycin in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2002, 768(2), 223-229.
[http://dx.doi.org/10.1016/S1570-0232(01)00566-9] [PMID: 11890168]
[12]
Jiang, Y.; Wang, J.; Li, H.; Wang, Y.; Gu, J. Determination of clarithromycin in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry. J. Pharm. Biomed. Anal., 2007, 43(4), 1460-1464.
[http://dx.doi.org/10.1016/j.jpba.2006.11.025] [PMID: 17174508]
[13]
Li, W.; Rettig, J.; Jiang, X.; Francisco, D.T.; Naidong, W. Liquid chromatographic-electrospray tandem mass spectrometric determination of clarithromycin in human plasma. Biomed. Chromatogr., 2006, 20(11), 1242-1251.2005,
[http://dx.doi.org/10.1002/bmc.691] [PMID: 16838265]
[14]
Wiesner, J.L.; Sutherland, F.C.; Smit, M.J.; van Essen, G.H.; Hundt, H.K.; Swart, K.J.; Hundt, A.F. Sensitive and rapid liquid chromatography-tandem mass spectrometry method for the determination of stavudine in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2002, 773(2), 129-134.
[http://dx.doi.org/10.1016/S1570-0232(02)00136-8] [PMID: 12031838]
[15]
Sastre Toraño, J.; Guchelaar, H.J. Quantitative determination of the macrolide antibiotics erythromycin, roxithromycin, azithromycin and clarithromycin in human serum by high-performance liquid chromatography using pre-column derivatization with 9-fluorenylmethyloxycarbonyl chloride and fluorescence detection. J. Chromatogr. B Biomed. Sci. Appl., 1998, 720(1-2), 89-97.
[http://dx.doi.org/10.1016/S0378-4347(98)00456-3] [PMID: 9892071]
[16]
Amini, H.; Ahmadiani, A. Sensitive determination of clarithromycin in human plasma by high-performance liquid chromatography with spectrophotometric detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2005, 817(2), 193-197.
[http://dx.doi.org/10.1016/j.jchromb.2004.12.003] [PMID: 15686985]
[17]
McNaught, A.D. Compendium of Chemical Terminology: IUPAC Recommendations; Blackwell Science, 1997.
[18]
Molnár, I.C.H. Reverse-phase chromatography of polar biological substances: separation of catechol compounds by high-performance liquid chromatography. J. Appl. Lab. Med., 1976, 22(9)
[19]
Mahmoud, M.E.; Randa, A.A.S.; Ghada, M.H. Robustness testing in HPLC analysis of clarithromycin, norfloxacin, doxycycline, tinidazole and omeprazole in pharmaceutical dosage forms using experimental design. Curr. Pharm. Anal., 2014, 10(1), 58-70.
[http://dx.doi.org/10.2174/157341291001140102111733]
[20]
United State Pharmacopoeia Clarithromycin for Oral Suspension.[(accessed on 12 April 2017)]; Available online:. http://www.drugfuture.com/Pharmacopoeia/usp36/PDF/1702-1703.pdf
[21]
Jorge, A.; Isabelle, A.; Elisabeth, B. Preparation of long‐chain esters of starch using fatty acid chlorides in the absence of an organic solvent. Starke, 1999, 51(4), 132-135.
[http://dx.doi.org/10.1002/(SICI)1521-379X(199904)51:4<132:AID-STAR132>3.0.CO;2-Z]
[22]
Bernhard, N.; Wolfgang, S. Simple method for the esterification of carboxylic acids. Angew. Chem. Int. Ed. Engl., 1978, 17(7), 522-524.
[http://dx.doi.org/10.1002/anie.197805221]

Rights & Permissions Print Cite
Article Metrics
11
1
© 2024 Bentham Science Publishers | Privacy Policy